Lymphatic mapping and sentinel lymphadenectomy for breast cancer

Giuliano, 1994, Lymphatic mapping and sentinel lymphadenectomy for breast cancer, Ann Surg, 220, 391, 10.1097/00000658-199409000-00015 Giuliano, 1997, Sentinel lymphadenectomy in breast cancer, J Clin Oncol, 15, 2345, 10.1200/JCO.1997.15.6.2345 Guenther, 1997, Sentinel lymphadenectomy for breast cancer in a community managed care setting, Cancer J Sci Am, 3, 336 Veronesi, 1997, Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes, Lancet, 349, 1864, 10.1016/S0140-6736(97)01004-0 Veronesi, 1999, Sentinel lymph node biopsy and axillary dissection in breast cancer, J Natl Cancer Inst, 91, 368, 10.1093/jnci/91.4.368 Borgstein, 1998, Sentinel lymph node biopsy in breast cancer guidelines and pitfalls of lymphoscintigraphy and gamma probe detection, J Am Coll Surg, 186, 275, 10.1016/S1072-7515(98)00011-8 Feldman, 1999, Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy, J Am Coll Surg, 188, 248, 10.1016/S1072-7515(98)00306-8 Moffat, 1999, Unfiltered sulfur colloid and sentinel node biopsy for breast cancer, Ann Surg Oncol, 6, 746, 10.1007/s10434-999-0746-4 Krag, 2001, Radiolabeled sentinel node biopsy, World J Surg, 25, 823, 10.1007/s00268-001-0012-9 Quan, 2002, Biology of lymphatic metastases in breast cancer, Ann Surg Oncol, 9, 467, 10.1007/BF02557270 Albertini, 1996, Lymphatic mapping and sentinel node biopsy in the patient with breast cancer, Jama, 276, 1818, 10.1001/jama.1996.03540220042028 O'Hea, 1998, Sentinel lymph node biopsy in breast cancer, J Am Coll Surg, 186, 423, 10.1016/S1072-7515(98)00060-X Molland, 2000, Sentinel node biopsy in breast cancer, Aust NZ J Surg, 70, 98, 10.1046/j.1440-1622.2000.01762.x Nano, 2002, Clinical impact of false-negative sentinel node biopsy in primary breast cancer, Br J Surg, 89, 1430, 10.1046/j.1365-2168.2002.02233.x Giuliano, 1995, Improved axillary staging of breast cancer with sentinel lymphadenectomy, Ann Surg, 222, 394, 10.1097/00000658-199509000-00016 Noguchi, 2002, Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes, Br J Surg, 89, 1505, 10.1046/j.1365-2168.2002.02294.x Krag, 1998, The sentinel node in breast cancer—a multicenter validation study, N Engl J Med, 339, 941, 10.1056/NEJM199810013391401 McMasters, 2000, Sentinel lymph node biopsy for breast cancer, J Clin Oncol, 18, 2560, 10.1200/JCO.2000.18.13.2560 Tafra, 2001, Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye, Ann Surg, 233, 51, 10.1097/00000658-200101000-00009 Bergkvist, 2001, Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer, Br J Surg, 88, 1644, 10.1046/j.0007-1323.2001.01948.x Shivers, 2002, Final results of the Department of Defense multicenter breast lymphatic mapping trial, Ann Surg Oncol, 9, 248, 10.1007/BF02573062 Giuliano, 2000, Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer, J Clin Oncol, 18, 2553, 10.1200/JCO.2000.18.13.2553 Luini, 2002, Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinoma, Arch Surg, 137, 1157, 10.1001/archsurg.137.10.1157 Liang, 2001, Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node?, Am J Surg, 182, 365, 10.1016/S0002-9610(01)00738-3 Chung, 2002, Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy, Am J Surg, 184, 310, 10.1016/S0002-9610(02)00956-X Turner, 1997, Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma, Ann Surg, 226, 271, 10.1097/00000658-199709000-00006 Sabel, 2001, Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma, J Surg Oncol, 77, 243, 10.1002/jso.1103 Stitzenberg, 2002, Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer, Am J Clin Pathol, 117, 729, 10.1309/7606-F158-UGJW-YBLE Krag, 1993, Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe, Surg Oncol, 2, 335, 10.1016/0960-7404(93)90064-6 Giuliano, 1997, Sentinel lymphadenectomy in breast cancer, J Clin Oncol, 15, 2345, 10.1200/JCO.1997.15.6.2345 Cody, 2001, Complementarity of blue dye and isotope in sentinel node localization for breast cancer, Ann Surg Oncol, 8, 13, 10.1007/s10434-001-0013-9 Derossis, 2001, A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer, J Am Coll Surg, 193, 473, 10.1016/S1072-7515(01)01038-9 Boolbol, 2001, Intradermal isotope injection, Ann Surg Oncol, 8, 20, 10.1007/s10434-001-0020-x Sardi, 2002, The benefit of using two techniques for sentinel lymph node mapping in breast cancer, Am Surg, 68, 24 Canavese, 2000, Sentinel lymph node mapping in early-stage breast cancer, J Surg Oncol, 74, 61, 10.1002/1096-9098(200005)74:1<61::AID-JSO14>3.0.CO;2-9 Motomura, 2001, Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients, J Surg Oncol, 76, 95, 10.1002/1096-9098(200102)76:2<95::AID-JSO1018>3.0.CO;2-D Lucci, 2001, National practice patterns of sentinel lymph node dissection for breast carcinoma, J Am Coll Surg, 192, 453, 10.1016/S1072-7515(01)00798-0 Martin, 2001, Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer, Surgery, 130, 432, 10.1067/msy.2001.116412 McMasters, 2001, Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy, Ann Surg, 233, 676, 10.1097/00000658-200105000-00012 McMasters, 2001, Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy, Ann Surg, 234, 292, 10.1097/00000658-200109000-00003 Vargas, 2002, A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer, Am Surg, 68, 87 Beitsch, 2001, Improved lymphatic mapping technique for breast cancer, Breast J, 7, 219, 10.1046/j.1524-4741.2001.20120.x Klimberg, 1999, Subareolar versus peritumoral injection for location of the sentinel lymph node, Ann Surg, 229, 860, 10.1097/00000658-199906000-00013 Bauer, 2002, Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer, Ann Surg Oncol, 9, 169, 10.1007/BF02557370 Tuttle, 2002, Subareolar injection of 99m Tc facilitates sentinel lymph node identification, Ann Surg Oncol, 9, 77, 10.1245/aso.2002.9.1.77 Kern, 1999, Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye, J Am Coll Surg, 189, 539, 10.1016/S1072-7515(99)00200-8 Kern, 2002, Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid, J Am Coll Surg, 195, 467, 10.1016/S1072-7515(02)01312-1 Balch, 2003, Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer, Ann Surg Oncol, 10, 616, 10.1245/ASO.2003.05.012 Solorzano, 2001, Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99m Tc-labeled sulfur colloid, Ann Surg Oncol, 8, 821, 10.1007/s10434-001-0821-y McCarter, 2001, Localization of the sentinel node in breast cancer, Ann Surg Oncol, 8, 682, 10.1007/s10434-001-0682-4 Linehan, 1999, Sentinel lymph node biopsy in breast cancer, J Am Coll Surg, 188, 377, 10.1016/S1072-7515(98)00314-7 Wilhelm AJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymph-node detection—an overview. Eur J Nucl Med 1999;26(Suppl 4):S36–42 Sadiq, 2001, Blue urticaria, Arch Surg, 136, 1433, 10.1001/archsurg.136.12.1433 Cimmino, 2001, Allergic reactions to isosulfan blue during sentinel node biopsy—a common event, Surgery, 130, 439, 10.1067/msy.2001.116407 Mokbel, 2001, The role of subareolar blue dye in identifying the sentinel node in patients with invasive breast cancer, Curr Med Res Opin, 17, 93, 10.1185/0300799039117035 Simmons, 2001, Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization, Breast J, 7, 181, 10.1046/j.1524-4741.2001.007003181.x Blessing, 2002, A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping, Am J Surg, 184, 341, 10.1016/S0002-9610(02)00948-0 Raimer, 1999, Dye rashes, Cutis, 63, 103 Stradling, 2002, Adverse skin lesions after methylene blue injections for sentinel lymph node localization, Am J Surg, 184, 350, 10.1016/S0002-9610(02)00945-5 Martin, 2001, Highest isotope count does not predict sentinel node positivity in all breast cancer patients, Ann Surg Oncol, 8, 592, 10.1007/s10434-001-0592-5 Winchester, 1999, Sentinel lymphadenectomy for breast cancer, J Am Coll Surg, 188, 597, 10.1016/S1072-7515(99)00060-5 McMasters, 2001, Sentinel lymph node biopsy for melanoma, Ann Surg Oncol, 8, 192, 10.1007/s10434-001-0192-4 McCarter, 2001, The breast cancer patient with multiple sentinel nodes, J Am Coll Surg, 192, 692, 10.1016/S1072-7515(01)00847-X Wong, 2001, Sentinel lymph node biopsy for breast cancer, J Am Coll Surg, 192, 684, 10.1016/S1072-7515(01)00858-4 Wong, 2002, The effect of lymphatic tumor burden on sentinel lymph node biopsy results, Breast J, 8, 192, 10.1046/j.1524-4741.2002.08402.x Ahrendt, 2002, Does breast tumor location influence success of sentinel lymph node biopsy?, J Am Coll Surg, 194, 278, 10.1016/S1072-7515(01)01174-7 Hill, 1999, Lessons learned from 500 cases of lymphatic mapping for breast cancer, Ann Surg, 229, 528, 10.1097/00000658-199904000-00012 Chao, 2001, Reliable lymphatic drainage to axillary sentinel lymph nodes regardless of tumor location within the breast, Am J Surg, 182, 307, 10.1016/S0002-9610(01)00717-6 Cox, 2002, Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer, Breast J, 8, 88, 10.1046/j.1524-4741.2002.08203.x Miner, 1999, Sentinel lymph node biopsy for breast cancer, Am Surg, 65, 493 Haigh, 2000, Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer, Ann Surg Oncol, 7, 21, 10.1007/s10434-000-0021-1 Wong, 2002, The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy, Ann Surg Oncol, 9, 272, 10.1007/BF02573065 Olson, 2000, Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer, J Am Coll Surg, 191, 593, 10.1016/S1072-7515(00)00732-8 Wong, 2001, Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers, Am Surg, 67, 522 Chung, 2001, Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer, Ann Surg Oncol, 8, 688 Breslin, 2000, Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer, J Clin Oncol, 18, 3480, 10.1200/JCO.2000.18.20.3480 Tafra, 2001, Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer, Am J Surg, 182, 312, 10.1016/S0002-9610(01)00718-8 Julian, 2001, Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer, Am J Surg, 182, 407, 10.1016/S0002-9610(01)00736-X Stearns, 2002, Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer, Ann Surg Oncol, 9, 235, 10.1007/BF02573060 Nason, 2000, Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma, Cancer, 89, 2187, 10.1002/1097-0142(20001201)89:11<2187::AID-CNCR6>3.0.CO;2-# Fernandez, 2001, Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme, Nucl Med Commun, 22, 361, 10.1097/00006231-200104000-00003 Klauber-DeMore, 2000, Sentinel lymph node biopsy, Ann Surg Oncol, 7, 636, 10.1007/s10434-000-0636-2 Cox, 2001, Importance of lymphatic mapping in ductal carcinoma in situ (DCIS), Am Surg, 67, 513 Liberman, 2000, Centennial dissertation. Percutaneous imaging-guided core breast biopsy, AJR Am J Roentgenol, 174, 1191, 10.2214/ajr.174.5.1741191 Won, 1999, Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device, AJR Am J Roentgenol, 173, 227, 10.2214/ajr.173.1.10397131 Burbank, 1997, Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions, Radiology, 202, 843, 10.1148/radiology.202.3.9051043 McMasters, 2002, Sentinel lymph node biopsy in patients with ductal carcinoma in situ, Cancer, 95, 15, 10.1002/cncr.10641 Burak, 1999, Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer, Am J Surg, 177, 445, 10.1016/S0002-9610(99)00088-4 McMasters, 2000, Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes, Ann Surg, 231, 724, 10.1097/00000658-200005000-00013 Dupont, 2001, The role of lymphoscintigraphy in the management of the patient with breast cancer, Ann Surg Oncol, 8, 354, 10.1007/s10434-001-0354-4 Haigh, 2000, Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy, J Nucl Med, 41, 1682 Jansen, 2000, Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer, Br J Surg, 87, 920, 10.1046/j.1365-2168.2000.01437.x Johnson, 2000, Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer, Am J Surg, 179, 386, 10.1016/S0002-9610(00)00365-2 Guenther, 2000, Selective lymphoscintigraphy, Arch Surg, 135, 1101, 10.1001/archsurg.135.9.1101 Carcoforo P, Basaglia E, Soliani G, et al. Sentinel node biopsy in the evaluation of the internal mammary node chain in patients with breast cancer. Tumori 2002;88(Suppl):S5–7 Dupont, 2001, Clinical relevance of internal mammary node mapping as a guide to radiation therapy, Am J Surg, 182, 321, 10.1016/S0002-9610(01)00720-6 Chung, 2002, Contemporary management of breast cancer, Obstet Gynecol Clin North Am, 29, 173, 10.1016/S0889-8545(03)00060-3 Yeatman TJ, Cox CE. The significance of breast cancer lymph node micrometastases. Surg Oncol Clin North Am 1999;8:481–96, ix Carter, 2000, Benign transport of breast epithelium into axillary lymph nodes after biopsy, Am J Clin Pathol, 113, 259, 10.1309/7EF8-F1W7-YVNT-H8H5 Singletary, 2002, Revision of the American Joint Committee on Cancer staging system for breast cancer, J Clin Oncol, 20, 3628, 10.1200/JCO.2002.02.026 Fitzgibbons, 2000, Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999, Arch Pathol Lab Med, 124, 966, 10.5858/2000-124-0966-PFIBC Turner, 1999, Intraoperative examination of the sentinel lymph node for breast carcinoma staging, Am J Clin Pathol, 112, 627, 10.1093/ajcp/112.5.627 Viale, 1999, Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients, Cancer, 85, 2433, 10.1002/(SICI)1097-0142(19990601)85:11<2433::AID-CNCR18>3.0.CO;2-3 Weiser, 2000, Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?, Ann Surg Oncol, 7, 651, 10.1007/s10434-000-0651-3 Chao, 2001, Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer, Am J Surg, 182, 609, 10.1016/S0002-9610(01)00794-2 Rubio, 1998, Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer, Ann Surg Oncol, 5, 689, 10.1007/BF02303478 Ratanawichitrasin, 1999, Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer, Br J Surg, 86, 1346, 10.1046/j.1365-2168.1999.01212.x Motomura, 2000, Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery, Br J Surg, 87, 597, 10.1046/j.1365-2168.2000.01423.x Henry-Tillman, 2002, Intraoperative touch preparation for sentinel lymph node biopsy, Ann Surg Oncol, 9, 333, 10.1007/BF02573867 Kane, 2001, Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection, Ann Surg Oncol, 8, 361, 10.1007/s10434-001-0361-5 Shiver, 2002, Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast, Am J Surg, 184, 424, 10.1016/S0002-9610(02)01003-6 Krag, 2001, Why perform randomized clinical trials for sentinel node surgery for breast cancer?, Am J Surg, 182, 411, 10.1016/S0002-9610(01)00728-0 Chu, 1999, Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?, Ann Surg, 229, 536, 10.1097/00000658-199904000-00013 Viale, 2001, Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma, Cancer, 92, 1378, 10.1002/1097-0142(20010915)92:6<1378::AID-CNCR1460>3.0.CO;2-Y Weiser, 2001, Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes, Ann Surg Oncol, 8, 145, 10.1007/s10434-001-0145-y Abdessalam, 2001, Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer, Am J Surg, 182, 316, 10.1016/S0002-9610(01)00719-X Wong, 2001, Predicting the status of the nonsentinel axillary nodes, Arch Surg, 136, 563, 10.1001/archsurg.136.5.563 Chua, 2001, Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma, Cancer, 92, 1769, 10.1002/1097-0142(20011001)92:7<1769::AID-CNCR1692>3.0.CO;2-6 Turner, 2000, Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node, Cancer, 89, 574, 10.1002/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y Ross MI. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA. Ann Surg Oncol 2001;8(Suppl 9):77S–81S Grube, 2001, Observation of the breast cancer patient with a tumor-positive sentinel node, Semin Surg Oncol, 20, 230, 10.1002/ssu.1038 Burak, 2002, Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer, Am J Surg, 183, 23, 10.1016/S0002-9610(01)00848-0 Schrenk, 2000, Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma, Cancer, 88, 608, 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K Haid, 2002, Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer, Eur J Surg Oncol, 28, 705, 10.1053/ejso.2002.1327 Swenson, 2002, Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer, Ann Surg Oncol, 9, 745, 10.1007/BF02574496 Giuliano, 1999, See one, do twenty-five, teach one, Ann Surg Oncol, 6, 520, 10.1007/s10434-999-0520-7 Cox, 1999, Implementation of new surgical technology, Ann Surg Oncol, 6, 553, 10.1007/s10434-999-0553-y Tafra, 2000, Credentialing issues with sentinel lymph node staging for breast cancer, Am J Surg, 180, 268, 10.1016/S0002-9610(00)00466-9 Ollila DW, Kelley MC, Hansen N, Giuliano AE. Independent experience of SSO trained surgical oncologists with lymphatic mapping for breast cancer. Proc Soc Surg Oncol 1999